Biotech Industry Marking a New Era Post-COVID-19

The inevitable need for a COVID-19 treatment has stirred up much-needed interest in Biotech industries all over the world. Here a straightforward take on Biotech industries post-COVID-19.

It is pretty astonishing how perceptions change in a short period of time. There was a time when Biotech companies were the most admired industries in the world. They invented vaccines for diseases like smallpox to polio, to delivering drugs for life-altering heart diseases.

Things went downhill when people started anti-vaccine campaigns refusing simple, cheap drugs that could change human life drastically. Presidents of the United States talking down on the pharma sector to Hollywood movies showing scientists and experts to be potentially crazy and dangerous.

Today, at the recent wake of the deadly COVID-19 pandemic, leaders, and experts are leaning on biotechnology and pharmaceutical companies in hope of finding a solution for this current deadly virus. Ranging from diagnostic tests to treatments, the biotech sector along with the help of the government is the only way to neutralize this current pandemic. It is currently up to us humans to give the time and chance for these efforts to mature.

Access Full PDF >>

Getting priorities straight:

Not a lot of pandemics have occurred in a century till date. However, research is a necessity for all diseases be it pandemic or not. The biotechnology industry works around the clock in a desperate attempt to find treatments or vaccines. For instance, the outbreak of polio startled the world by killing almost 3000 children around the world. By late 1957, due to the combined efforts of WHO and pharma companies, a vaccine was developed, bringing down the number of cases drastically and eventually diminishing quickly around the globe.

Today, not many people around the world are aware of the concerns regarding infectious diseases. A major part of the lack of awareness is due to the lack of perceived need. Over the last few decades, investors have put in very few resources in regard to developing a treatment for infectious diseases.

Today, COVID-19 has abruptly pushed all focus onto the infectious disease. This will keep people aware and more prepared to prevent any such pandemics in the future. With the focus shifting to COVID-19, data from pre-existing trials regarding other diseases have come to an abrupt halt. As the trial recruitment come to a halt, the healthcare sector prioritizes COVID-19 patients.

Biotechn Industry Top Players :

Thermo Fisher Scientific Inc., Merck KGaA, PerkinElmer, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Danaher, QIAGEN, BD, Bio-Rad Laboratories, Inc., Illumina, Inc. and among others.

The global biotechnology Indutsry is highly competitive and driven by large number of novel product launches and approvals.

Access Full PDF >>

READ MORE ABOUT BIOTECH INDUSTRY